To further validate our results, we applied this treatment regimen to the TMZ-resistant GBM cell line T98G, cells with endogenous elevated expression of MGMT, as compared to the TMZ-sensitive cell line U87MG, as a control (Figure 5D). Here, MGMT is linked to glioblastoma.